Journal rankings · indicator year 2021
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2021
Hematology journal rankings 2021
83 ranked journals · Subfield in Medicine
Hematology has 83 ranked journals in 2021. The median journal has an OJR of 0.68, below the world average of 1.00, down 0.03 on 2020; Q1 starts at OJR 1.19. The top three are The Lancet Haematology, Journal of Thrombosis and Haemostasis, and Blood.
Ranks and citation indicators: 2021. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2018–2020, the window the 2021 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery985
- Pulmonary and Respiratory Medicine362
- Public Health, Environmental and Occupational Health303
- Cardiology and Cardiovascular Medicine297
- Oncology239
- Infectious Diseases234
- Epidemiology204
- Neurology172
- Radiology, Nuclear Medicine and Imaging170
- Endocrinology, Diabetes and Metabolism163
- Physiology163
- Psychiatry and Mental health145
- Hematology83
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology99
- Obstetrics and Gynecology83
- Rheumatology67
- Nephrology61
- Pharmacology54
- Complementary and alternative medicine50
- Reproductive Medicine49
- Emergency Medicine45
- Geriatrics and Gerontology39
- Rehabilitation37
- Otorhinolaryngology35
- Hepatology29
- Pathology and Forensic Medicine26
- Critical Care and Intensive Care Medicine24
- Immunology and Allergy23
- Genetics20
- Anesthesiology and Pain Medicine14
- Urology14
- Gastroenterology6
- Health Informatics5
- Internal Medicine5
- Transplantation3
- Family Practice2
- Biochemistry1
- Anatomy0
- Microbiology0
83 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2020. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2018–2020, the window the 2021 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2018–2020 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2012 to 2021. | Compare |
|---|---|---|---|---|---|---|---|
1The Lancet HaematologyElsevier BV · Netherlands | 3.92Q1 | 15.97 7.61 up from 2020 | 354 | 37% | $7,280 | ||
2Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 3.25Q1 | 15.99 10.62 up from 2020 | 988 | 97% | $3,750 | ||
3BloodElsevier BV · United States | 3.21Q1 | 12.17 1.82 up from 2020 | 2,290 | 17% | $5,500 | ||
4LeukemiaSpringer Nature · United Kingdom | 2.73Q1 | 10.06 1.32 up from 2020 | 1,045 | 78% | $5,190 | ||
5Blood ReviewsElsevier BV · United Kingdom | 2.60Q1 | 9.55 0.03 up from 2020 | 188 | 43% | $5,220 | ||
6Blood Cancer JournalOASpringer Nature · United Kingdom | 2.33Q1 | 7.79 0.52 up from 2020 | 348 | 100% | $5,290 | ||
7Blood AdvancesOAElsevier BV · United States | 2.28Q1 | 8.39 1.13 up from 2020 | 1,448 | 100% | $3,800 | ||
8American Journal of HematologyWiley · United States | 1.97Q1 | 7.78 2.61 up from 2020 | 928 | 81% | $5,450 | ||
9Transfusion Medicine ReviewsElsevier BV · United States | 1.70Q1 | 8.72 4.24 up from 2020 | 90 | 28% | $3,970 | ||
10Blood Cancer DiscoveryAmerican Association for Cancer Research · United States | 1.68Q1 | 6.33no 2020 value | 42 | 98% | — | — | |
11HaematologicaOAFerrata Storti Foundation · Italy | 1.67Q1 | 5.73 0.43 up from 2020 | 1,565 | 100% | $2,157 | ||
12Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.63Q1 | 5.98 2.32 down from 2020 | 110 | 100% | $2,650 | ||
13Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.47Q1 | 4.95 0.39 up from 2020 | 170 | 27% | $3,790 | ||
14Pediatric RheumatologyOABioMed Central · United Kingdom | 1.39Q1 | 4.08 0.41 up from 2020 | 255 | 100% | $3,090 | ||
15Research and Practice in Thrombosis and HaemostasisOAElsevier BV · United States | 1.33Q1 | 5.22 0.84 up from 2020 | 345 | 100% | $2,250 | ||
15HematologyAmerican Society of Hematology · United States | 1.33Q1 | 3.59 0.35 down from 2020 | 254 | 100% | — | ||
17Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 1.29Q1 | 4.29 1.05 up from 2020 | 133 | 15% | $3,730 | ||
18British Journal of HaematologyWiley · United Kingdom | 1.28Q1 | 4.94 1.36 up from 2020 | 1,817 | 74% | $5,190 | ||
19AnemiaOAHindawi Publishing Corporation · United Kingdom | 1.27Q1 | 2.55 3.90 down from 2020 | 44 | 100% | $1,100 | ||
20Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.26Q1 | 4.14 0.52 down from 2020 | 1,124 | 100% | $3,650 | ||
21Seminars in HematologyElsevier BV · United States | 1.19Q1 | 3.12 1.19 down from 2020 | 107 | 28% | $4,070 | ||
22BMC HematologySpringer Science+Business Media · United Kingdom | 1.06Q2 | 3.80 0.11 down from 2020 | 47 | — | $2,170 | ||
23Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.05Q2 | 3.92 0.42 up from 2020 | 1,037 | 52% | $4,990 | ||
24Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 1.05Q2 | 3.99 0.54 up from 2020 | 168 | 100% | $1,670 | ||
25European Journal Of HaematologyWiley · United Kingdom | 1.02Q2 | 3.65 0.58 up from 2020 | 501 | 49% | $4,650 | ||
26PlateletsOAInforma · United Kingdom | 1.02Q2 | 3.60 0.85 up from 2020 | 442 | 42% | $2,970 | ||
27Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.02Q2 | 3.27 0.19 up from 2020 | 184 | 49% | — | ||
28Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 1.00Q2 | 6.20 2.41 up from 2020 | 289 | 40% | — | ||
29Expert Review of HematologyTaylor & Francis · United Kingdom | 0.95Q2 | 3.24 0.05 up from 2020 | 299 | 23% | — | ||
30Current Research in Translational MedicineElsevier BV · France | 0.93Q2 | 4.27 0.84 up from 2020 | 86 | 38% | $3,700 | ||
31Journal of Blood MedicineOADove Medical Press · New Zealand | 0.90Q2 | 2.74 0.12 down from 2020 | 140 | 100% | $2,320 | ||
32Annals of HematologyOASpringer Science+Business Media · Germany | 0.85Q2 | 3.22 0.63 up from 2020 | 1,108 | 38% | $4,590 | ||
33Vox SanguinisWiley · United Kingdom | 0.85Q2 | 3.29 1.46 up from 2020 | 365 | 41% | $4,150 | ||
34Experimental HematologyElsevier BV · United States | 0.84Q2 | 3.00 0.05 down from 2020 | 272 | 100% | $3,250 | ||
35HemaSphereOAWolters Kluwer · United States | 0.82Q2 | 2.73 0.34 up from 2020 | 323 | 100% | $2,480 | ||
36Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.77Q2 | 3.03 0.25 down from 2020 | 220 | 100% | $647 | ||
37Annals of Laboratory MedicineOASeoul National University · South Korea | 0.76Q2 | 3.45 0.86 up from 2020 | 318 | 100% | — | ||
38HaemophiliaWiley · United Kingdom | 0.75Q2 | 3.23 0.66 up from 2020 | 732 | 44% | $4,760 | ||
39Leukemia ResearchElsevier BV · United Kingdom | 0.75Q2 | 2.57 0.16 up from 2020 | 467 | 14% | $3,910 | ||
40Journal of Clinical ApheresisWiley · United States | 0.73Q2 | 3.38 0.50 down from 2020 | 219 | 28% | $3,920 | ||
41International Journal of HematologySpringer Science+Business Media · Japan | 0.72Q2 | 2.53 0.37 up from 2020 | 576 | 19% | $4,390 | ||
42Cytometry Part B Clinical CytometryWiley · United States | 0.68Q2 | 3.09 0.47 up from 2020 | 206 | 66% | $3,800 | ||
43TransfusionWiley · United States | 0.68Q3 | 2.94 0.15 up from 2020 | 1,448 | 35% | $4,100 | ||
44Acta HaematologicaKarger Publishers · Switzerland | 0.66Q3 | 2.85 1.27 up from 2020 | 330 | 33% | — | ||
45International Journal of Laboratory HematologyWiley · United Kingdom | 0.65Q3 | 2.75 0.61 up from 2020 | 621 | 29% | $3,880 | ||
46Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.64Q3 | 2.18 0.24 down from 2020 | 753 | 10% | $3,890 | ||
47HematologyOAManey Publishing · United Kingdom | 0.62Q3 | 2.34 0.01 down from 2020 | 245 | 100% | $2,557 | ||
48Transfusion and Apheresis ScienceElsevier BV · United Kingdom | 0.61Q3 | 2.83 1.06 up from 2020 | 600 | 34% | $3,160 | ||
49Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.60Q3 | 1.97 0.04 up from 2020 | 1,322 | 26% | — | ||
50HämostaseologieThieme Medical Publishers (Germany) · Germany | 0.59Q3 | 2.41 1.07 up from 2020 | 163 | 24% | — |
Subfields of Medicine, with Hematology highlighted.
- Surgery985
- Pulmonary and Respiratory Medicine362
- Public Health, Environmental and Occupational Health303
- Cardiology and Cardiovascular Medicine297
- Oncology239
- Infectious Diseases234
- Epidemiology204
- Neurology172
- Radiology, Nuclear Medicine and Imaging170
- Endocrinology, Diabetes and Metabolism163
- Physiology163
- Psychiatry and Mental health145
- Orthopedics and Sports Medicine124
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology99
- Hematology83
- Obstetrics and Gynecology83
- Rheumatology67
- Nephrology61
- Pharmacology54
- Complementary and alternative medicine50
- Reproductive Medicine49
- Emergency Medicine45
- Geriatrics and Gerontology39
- Rehabilitation37
- Otorhinolaryngology35
- Hepatology29
- Pathology and Forensic Medicine26
- Critical Care and Intensive Care Medicine24
- Immunology and Allergy23
- Genetics20
- Anesthesiology and Pain Medicine14
- Urology14
- Gastroenterology6
- Health Informatics5
- Internal Medicine5
- Transplantation3
- Family Practice2
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2021. Corpus-wide, 87.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
20 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2018–2020, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2021. Publication window: 2018–2020. How these summaries are calculated
- Ranked journals
- 83
- Window papers (baseline)
- 43,037 +14.1% from indicator year 2018
- Median OJR
- 0.682 -8.4% from indicator year 2018
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2018–2020 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.